Dermapharm

Dermapharm, based near Munich, is a maker of branded pharmaceuticals and healthcare products, built on a portfolio of off-patent medicines, dermatology brands and dietary supplements. Its integrated model, from development to production, gives it steady margins in defensive healthcare niches. Dermapharm has paid and grown its dividend since listing, funded by dependable cash flow, though acquisitions and investment have kept the payout moderate. A steady, growing yield from a resilient healthcare business defines its profile, appealing to investors who want dependable income with a defensive tilt.